2026 EHA | Over 40 Orelabrutinib Studies Presented, Including First Clinical Data from Europe and US TN CLL/SLL Patients
BEIJING, June 15, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE:…
Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress
Poster presentations from ongoing clinical trials of two core assets, olverembatinib and…
Modat adds Passive DNS to its Platform Magnify, Connecting Every Signal in a Single Investigation Graph
THE HAGUE, the Netherlands, June 14, 2026 (GLOBE NEWSWIRE) -- Modat today…
XM Announces Enhanced Trading Conditions and Opportunities for Global Traders – Featuring Partner Code 274PQ
TORONTO, June 14, 2026 (GLOBE NEWSWIRE) -- As participation in online financial…
FemiCore [Exclusive Report 2026] Femi Core Warning Why Thousands of Women Are Suddenly Talking About This Bladder Health Supplement
New York City, NY, June 13, 2026 (GLOBE NEWSWIRE) -- In a…
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Achieved 100% ORR and 83.3% CR rate at dose level 2 following…
KFSH Highlights Human-Centered AI as a Path to Better Care at HLTH Europe 2026
RIYADH, Saudi Arabia, June 14, 2026 (GLOBE NEWSWIRE) -- At HLTH Europe…
Phase 3 Data Show TransCon PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism
June 13, 2026 16:00 ET | Source: Ascendis Pharma Multi-organ system and…
FemiCore (Official Website & Authenticity Notice 2026) Counterfeit Risks and What Consumers Should Know
New York City, NY, June 13, 2026 (GLOBE NEWSWIRE) -- The women's…
Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance
BEIJING, June 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Hitch Open Ping-Pong…


